Mitigating the cardiovascular and renal effects of NSAIDs (Q27022837)

James D. Katz

series ordinal

2

1 reference

language of work or name

1 reference

December 2013

1 reference

1 reference

14 Suppl 1

1 reference

PubMed

page(s)

S23-8

1 reference

EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

PubMed

cites work

1 reference

OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines

21 January 2018

1 reference

The NSAID dilemma: managing osteoarthritis in high-risk patients

21 January 2018

1 reference

Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders

21 January 2018

1 reference

Prescription patterns and appropriateness of NSAID therapy according to gastrointestinal risk and cardiovascular history in patients with diagnoses of osteoarthritis

21 January 2018

1 reference

Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities

21 January 2018

1 reference

Increased Prostacyclin Biosynthesis in Patients with Severe Atherosclerosis and Platelet Activation

21 January 2018

1 reference

Coxibs and cardiovascular disease

21 January 2018

1 reference

Cyclooxygenase inhibition and cardiovascular risk

21 January 2018

1 reference

Prospects for changing the burden of nonsteroidal anti-inflammatory drug toxicity

21 January 2018

1 reference

Cyclooxygenase-2 and kidney failure

21 January 2018

1 reference

The complex interplay between cyclooxygenase-2 and angiotensin II in regulating kidney function

21 January 2018

1 reference

E Prostanoid-1 receptor regulates renal medullary alphaENaC in rats infused with angiotensin II.

21 January 2018

1 reference

Low plasma renin and reduced renin secretory responses to acute stimuli in conscious COX-2-deficient mice

21 January 2018

1 reference

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

21 January 2018

1 reference

Focus on the COX-1 and COX-2 agents: renal events of nonsteroidal and anti-inflammatory drugs-NSAIDs

21 January 2018

1 reference

Should nonsteroidal anti-inflammatory drugs (NSAIDs) be prescribed to the older adult?

21 January 2018

1 reference

Renal effects of COX-2-selective inhibitors

21 January 2018

1 reference

Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population

21 January 2018

1 reference

Clinical pharmacology of platelet cyclooxygenase inhibition

21 January 2018

1 reference

Pharmacokinetics of ibuprofen in febrile children

21 January 2018

1 reference

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

21 January 2018

1 reference

Effect of ibuprofen on cardioprotective effect of aspirin

21 January 2018

1 reference

Effects of ibuprofen on the magnitude and duration of aspirin's inhibition of platelet aggregation: clinical consequences in stroke prophylaxis

21 January 2018

1 reference

Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease

21 January 2018

1 reference

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

21 January 2018

1 reference

Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study

21 January 2018

1 reference

Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association

21 January 2018

1 reference

Systemic bioavailability of topical diclofenac sodium gel 1% versus oral diclofenac sodium in healthy volunteers

21 January 2018

1 reference

Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction

21 January 2018

1 reference

Optimal suppression of thromboxane A(2) formation by aspirin during percutaneous transluminal coronary angioplasty: no additional effect of a selective cyclooxygenase-2 inhibitor

21 January 2018

1 reference

Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear str

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/PME.12275

0 references

PubMed publication ID

24255997

1 reference